Contact
Please use this form to send email to PR contact of this press release:
Results from 10-week analysis of Phase 2 study with filgotinib in Crohn's Disease presented at ECCO
TO:
Please use this form to send email to PR contact of this press release:
Results from 10-week analysis of Phase 2 study with filgotinib in Crohn's Disease presented at ECCO
TO: